Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:xiao5playgame
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To evaluate the possible role of Tribble 3 (TRB3) in a rat model of non-alcoholic fatty liver disease (NAFLD) and its signal transduction mechanism. METHODS: Thi r ty Sprague-Dawley rats were randomized into three groups: normal control group,non-alcoholic fatty liver group A (fed on a highfat diet for 8 wk) and group B (fed on a high-fat diet for 16 wk). To determine the degree of hepatic steatosis in rats of each group, livers were stained with hematoxylin and eosin, and evaluated; realtime fluorescent quantitative reverse transcriptasepolymerase chain reaction was performed to measure the expression levels of TRB3 mRNA; and West blotting analysis was done to determine the expression levels of protein kinase B (Akt) and phosphorylated protein kinase B (p-Akt-Thr308, p-Akt-Ser473). RESULTS: Hepatic steatosis was evident in both NAFLD groups: mild to moderate hepatic steatosis occurred in group A, mainly as mild steatosis. Moderate to severe hepatic steatosis occurred in group B, mainly as severe steatosis. The expression level of TRB3 mRNA in group B was significantly higher than in the control group (122.28 ± 95.37 vs 3.06 ± 2.33,P = 0.001) and group A (122.28 ± 95.37 vs 5.77 ± 4.20,P = 0.001). There was no significant difference in the expression levels of Akt (1.03 ± 0.53 vs 1.12 ± 0.77,P = 0.729) and p-Akt-Thr308 (0.82 ± 0.45 vs 0.92 ± 0.38, P = 0.592) between group A and the control group. The expression level of Akt and p-Akt-Thr308 in group B was significantly lower than in group A (Akt 0.41 ± 0.16 vs 1.12 ± 0.77, P = 0.008; p-Akt-Thr308 0.47 ± 0.19 vs 0.82 ± 0.45, P = 0.036) and the control group (Akt 0.41 ± 0.16 vs 1.03 ± 0.53, P = 0.018; p-Akt-Thr308 0.47 ± 0.19 vs 0.92 ± 0.38, P = 0.010).The expression level of p-Akt-Ser473 in group A was significantly higher than in group B (1.48 ± 0.50 vs 0.81 ± 0.39, P = 0.041) as well as the control group (1.48 ± 0.50 vs 0.45 ± 0.26, P = 0.003).CONCLUSION: TRB3 blocks insulin signaling by inhibiting Akt activation, which contributes to insulin resistance. It may be an important factor in the occurrence and development of NAFLD.
其他文献
目的:对比杂交手术(Hybrid)与术中支架结合左锁骨下-左颈总动脉移植术在累及弓远端的B型夹层中应用的效果.方法:收集自2010年3月至2016年11月,安贞医院采取杂交手术及术中支
近几年来,糖尿病高危人群在不断的增加,而安徽中医院国家中医临床研究基地经过3年研究,初步建立起糖尿病前期管理模式.该基地在安徽、浙江等省的10余家医疗机构和基层医疗单
目的 众所周知,高血压前期与心血管疾病和胰岛素抵抗是相关的.然而.高血压前期是不是糖尿病的一个危险因素,却不得而知.本文主要研究高血压前期是否是2型糖尿病发生的一个危
目的 探讨多种微创方法治疗下肢静脉曲张的疗效及并发症观察.方法 选择重庆市红十字会医院2018年1月至~2019年1月收治的100例下肢静脉曲张患者,根据患者治疗方法不同分分为A组
目的 观察中药内服联合西药治疗糖尿病周围血管病变(DPVD)的临床效果.方法 入选2017年8月至2018年8月的糖尿病周围血管病变(DPVD)患者68例,随机的分成对照组34例,观察组34例,
三高的饮食习惯、缺乏户外活动和锻炼、不健康的生活方式,让我国的儿童糖尿病人数不断上升.有关调查研究显示,通常临床上11 ~14岁是儿童糖尿病高发年龄.我国目前有5000多万糖
目的 探讨肝硬化联合门静脉血栓形成的危险因素及预后的效果.方法 选择福建省立医院干部特诊科2015年1月至2019年1月收治的肝硬化联合门静脉血栓患者58例为观察组与肝硬化无
目的 分析用生脉散汤剂治疗糖尿病并发冠心痛心绞痛的效果.方法 2017年4月~2018年5月,医院门诊说只糖尿病并发冠心病心绞痛患者90例,按照入院顺序随机分组,对照组、观察组各45